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INTRODUCTION
Allergic rhinitis (AR) has been shown to be a risk factor for the 
development of asthma.1,2 Lower airway pathology of AR may 
represent the link between these 2 diseases.3 Airway inflamma-
tion, bronchial hyper-responsiveness (BHR), and bronchodila-
tor response (BDR) are representative characteristics of asth-
ma. These have also been evaluated in AR in order to assess the 
degree of involvement of the peripheral airways.4,11 BHR in a 
methacholine challenge test (MCT) in AR has been suggested 
as a possible predictor of progression of AR to asthma.4,11 In cas-
es of perennial AR, BHR may affect up to 80% of patients.5,6 
Fractional exhaled nitric oxide (FeNO) has been studied in AR 
as a useful tool for detecting airway inflammation.7,8
The reversibility of airway obstruction is considered a diag-
nostic criterion for asthma and is a useful tool for evaluating 
lower airway pathology.9 While reversibility is determined by 
an increase in forced expiratory volume in 1 second (Δ FEV1)≥
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12% after inhalation of a bronchodilator in an adult, such a cri-
terion has not yet been established in children.10 There have 
been few studies on BDR in AR children. Two different defini-
tions of BDR assessed by spirometry have been proposed in AR 
children: Δ FEV1≥7.53% and Δ FEV1≥12%.11,12
Impulse oscillometry (IOS) has emerged as a powerful tool for 
evaluating pulmonary function in children who have failed to 
undergo forced expiration testing or show small changes in pul-
monary function.13 Given this sensitivity, it is also useful for the 
evaluation of mild asthma or eosinophilic bronchitis, neither of 
which may be detected by spirometry.14 To the best of our 
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Purpose: Airway inflammation, bronchial hyper-responsiveness (BHR), and bronchodilator response (BDR) are representative characteristics of asth-
ma. Because allergic rhinitis (AR) is a risk factor for asthma development, we evaluated these 3 characteristics in AR using measurement of fractional 
exhaled nitric oxide (FeNO), a methacholine challenge test (MCT), and impulse oscillometry (IOS). Methods: This study included 112 children with 
asthma (asthma group), 196 children with AR (AR group), and 32 control subjects (control group). We compared pulmonary function parameters and 
FeNO levels among the 3 groups. The AR group was subdivided into 2 categories: the AR group with BHR and the AR group without, and again pulmo-
nary function and FeNO levels were compared between the 2 subgroups. Results: FeNO levels were more increased in the AR and asthma groups 
than in the control group; within the AR group, FeNO was higher in the AR group with BHR than in the AR group without. The BDR was more increased 
in the AR group than in the control group when percent changes in reactance at 5 Hz (Δ X5) and reactance area (Δ AX) were compared. In the AR group, 
however, there was no difference in Δ X5 and Δ AX between the AR group with BHR and the AR group without. Conclusions: Reversible airway 
obstruction on IOS and elevated FeNO levels were observed in children with AR. Because elevated FeNO levels can indicate airway inflammation and 
because chronic inflammation may lead to BHR, FeNO levels may be associated with BHR in AR. IOS can be a useful tool for detecting lower airway 
involvement of AR independent of BHR assessed in the MCT.
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knowledge, there have been few studies evaluating BHR in AR 
using IOS or to evaluate BDR in AR using IOS.15
The aim of this study was to evaluate BDR in the AR, asthma, 
and control groups. Furthermore, we sought to delineate the re-
lationship among BHR, airway inflammation, and BDR in the 
AR group using MCT, FeNO measurement, and IOS.
 
MATERIALS AND METHODS
Subjects
This study included a total of 340 children who visited Sever-
ance Children’s Hospital between July 2006 and August 2011. 
The children were divided into 3 groups: those who had atopic 
asthma and AR (asthma group, n=112), those who had AR 
without asthma (AR group, n=196) and those who had neither 
asthma nor AR (control group, n=32). Atopic asthma was de-
fined as a Δ FEV1≥12% in response to a short-acting broncho-
dilator or BHR in the MCT (PC20≤16 mg/mL) accompanied 
by any typical asthma symptoms, such as cough or dyspnea.16 
Of the 196 children in the AR group, 24 had BHR in the MCT 
(PC20≤16 mg/mL) without any typical asthma symptoms, 
such as cough or dyspnea, and the remaining 172 did not have 
BHR in the MCT (PC20>16 mg/mL). The control group showed 
normal spirometric results but had neither a history of respira-
tory disease, parenchymal lung abnormalities, BHR, nor BDR. 
We excluded non-atopic subjects based on allergy screening 
tests as well as subjects with asthma and without AR. Subjects 
had no history of respiratory infection for at least 6 weeks prior 
to the evaluation. We excluded subjects who had taken inhaled 
or systemic corticosteroids or leukotriene antagonists within 8 
weeks prior to the study. All subjects were instructed to discon-
tinue their β2-agonist medications for at least 3 days prior to 
pulmonary function and methacholine challenge tests.
Serum total and specific immunoglobulin E (IgE) levels and 
peripheral blood eosinophil counts were measured, and skin 
prick tests were performed at the initiation of the evaluation. 
IOS and spirometry were performed at the second visit, with 
IOS being performed prior to spirometry in order to avoid any 
influence of forced expiratory maneuvers on airway function 
during breathing at rest. Finally, FeNO was measured before 
the MCT and the MCT was performed at the third visit because 
repetitive exhalations of methacholine could decrease the 
FeNO levels. This study was approved by the Institutional Re-
view Board of Severance Hospital (Seoul, Korea).
Allergy screening tests
Total and specific serum IgE levels were measured using the 
Pharmacia CAP assay (Uppsala, Sweden). A specific IgE test 
was performed for 6 allergens commonly encountered in Ko-
rea: Dermatophagoides pteronyssinus, Dermatophagoides fari-
na, egg white, cow milk, German cockroach, and Alternaria al-
ternata. Atopy was defined as IgE levels greater than 0.7 kU/L 
that were specific to more than 1 allergen or total IgE levels 
greater than 150 IU/mL. Atopy was also defined as a positive 
skin reaction to more than 1 out of the 12 common aeroaller-
gens, including 2 types of dust mites, cat and dog epithelium, as 
well as mold and pollen allergens, such as Alternaria, Aspergil-
lus, birch, oak, mugwort, Japanese hop, ragweed, and bermuda 
grass. A saline solution was used as a negative control and a 
0.5% histamine HCL (hydrochloric acid) solution was used as a 
positive control. Wheal diameters were measured after 15 min-
utes; a positive reaction was defined as a wheal diameter greater 
than 3 mm.17 All subjects had atopy according to these criteria.
Spirometry and the MCT
A Jaeger MasterScreen PFT (pulmonary function test) system 
(Jaeger Co, Wurzberg, Germany) was used. Flow-volume 
curves were obtained before and after bronchodilator (BD) in-
halation according to the American Thoracic Society guide-
lines.18 The MCT was performed according to standardized pro-
cedures.16 Each child inhaled increasing concentrations of 
methacholine (0.075, 0.15, 0.31, 0.62, 1.25, 2.5, 5, 10, 25, and 50 
mg/mL) nebulized by a dosimeter (MB3; Mefar; Brescia, Italy) 
until FEV1 was reduced by 20% from a post-nebulized saline 
solution value. BHR was expressed as the provocative concen-
tration of methacholine causing FEV1 to decrease by 20% 
(PC20, mg/mL). This was calculated by linear interpolation of 
the log dose-response curve.
FeNO measurement
FeNO was measured using a CLD 88 (Eco Medics, Duernten, 
Switzerland) at a constant expiratory flow rate of 50 mL/s. The 
measurements were made according to the ERS/ATS guide-
lines.19 Since nitrate-rich foods could affect FeNO levels, all chil-
dren refrained from eating nitrate-rich foods for 2 hours before 
measurement of FeNO. The mean value of the 3 consecutive 
measurements was calculated and regarded as the actual value.
Impulse oscillometry
The Jaeger MasterScreen IOS system (Jaeger Co, Wurzberg, 
Germany) was used to perform impulse oscillometry. Mea-
surements were made according to the ERS/ATS guidelines 
and repeated just before spirometry after bronchodilator ad-
ministration.20 The system was calibrated through a single vol-
ume of air (3 L) at different flow rates, with a reference device 
(0.2 kPa/L/s). The machine was also calibrated to the air tem-
perature and pressure of the saturated gas. The impulse genera-
tor produced brief pressure pulses at intervals of 0.2 second. In 
this study, mean resistance (R) values were calculated over a 
measurement period of 60 seconds at frequencies of 5 Hz (R5) 
and 10 Hz (R10). Reactance (X) values were measured at 5 Hz 
(X5). We also recorded reactance area (AX), an integrated re-
sponse index for reactance developed by Goldman,20 which re-
flects the integral of the negative values of reactance from 5 Hz 
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to the resonant frequency. R5 reflects obstruction in the total 
airways, R20 only reflects the large airways, and the difference 
between R5 and R20 (R5-R20) is a parameter of the small air-
way alone. X5 and AX also reflect the degree of obstruction in 
the peripheral airways.21
During IOS, children sat upright with their heads resting 
against the back of the chair. They used nose clips and were in-
structed to breathe quietly through a mouthpiece. To decrease 
the shunt compliance of the cheeks, an investigator stood be-
hind the patient and supported both the cheeks and the chin 
with their hands. Observations did not show any artifacts 
caused by coughing, breath holding, swallowing, or vocaliza-
tion. Three correct measurements were averaged at each time 
point. We used acceptable coherence values of ≥0.8 at 10 Hz.21
Statistical analysis
The values with a parametric distribution in the text and ta-
bles are expressed as mean±SD. Values with a non-parametric 
distribution are expressed as median with interquartile ranges. 
Patients’ characteristics, spirometric results, FeNO levels, and 
IOS values were evaluated using analysis of variance (ANOVA) 
for comparison of the 3 groups, using t tests or Fisher’s exact 
tests for comparison of 2 groups if the data were parametric and 
continuous, and using the Kruskal-Wallis test and the Mann-
Whitney test if the data were non-parametric and continuous. 
If the data were categorical variables, we used chi-square tests. 
We also compared the AR group with BHR to that without. Cor-
relation coefficients between FeNO and PC20 levels were cal-
culated with Pearson product moment correlation.
A P value of <0.05 was considered statistically significant. The 
Statistical Package for the Social Sciences (version 18.0, SPSS 
Inc., Chicago, IL, USA) was used for all analyses.
 
RESULTS
Clinical characteristics
The clinical characteristics of the patients in this study are 
shown in Table 1. The 3 groups did not differ in terms of age, 
sex, and height. Serum total IgE levels and blood eosinophil 
counts were significantly higher in the AR and asthma groups 
than in the control group (P<0.05). Skin tests were performed 
on 224 children. The frequency of positive skin reactions was 
higher in the AR and asthma groups than in the control group 
(P<0.05). FEV1, the FEV1/forced expiratory vital capacity 
(FVC), and forced expiratory flow between 25% and 75% (FEF25-75) 
were significantly lower in the asthma group than in the AR and 
control groups (P<0.0001). There were no significant differenc-
es in FEV1, FEV1/FVC, or FEF25-75 between the AR and control 
groups.
The MCT and FeNO measurement
BHR of the 3 groups as assessed by the MCT and FeNO levels 
lated with PC20 levels (r=-0.337, P<0.0001) (E-Table 1).
 
Bronchodilator response on spirometry and impulse 
oscillometry 
BDR parameters as determined by spirometry and IOS in the 
asthma, AR, and control groups are shown in Table 3. The Δ 
Table 1. Subject characteristics
Asthma
(n=112)
Allergic rhinitis
(n=196)
Control
(n=32)
Age (years) 9.6 
(7.6/11.1)
9.2 
(7.9/11.1)
10.6 
(8.5/12.7)
Male (no [%]) 70 (63) 139 (71) 18 (56)
Height (cm) 136 
(126/144)
136 
(127/149)
140 
(128/157)
Total IgE (IU/mL) 358 
(154/689)*†
 252  
(132/499)*
169 
(97/269)
Blood eosinophil (µL-1) 480
 (230/755)*†
 360  
(190/560)*
255 
(140/328)
Positive skin test  
(n=224) (no [%])
71 (96)* 131 (97)* 12 (80)
Spirometry
FEV1 (% predicted) 95.3±16.0*† 102.3±13.6 106.5±12.4
FVC (% predicted) 98.7  
(89.8/106.3)
97.8  
(84.6/105.9)
98.1  
(90.4/109.9)
FEV1/FVC (%) 81.8 
(76.8/89.5)*†
89.9  
(86.3/97.2)
90.6  
(86.1/94.9)
FEF25-75, (% predicted) 69.8 
(57.3/89.6)*†
101.0 
(86.4/114.6)
102.2 
(90.5/111.4)
Data expressed as number (percent), mean±SD, or median (interquartile range). 
*P<0.05 vs. control; †P<0.05 vs. Allergic Rhinitis.
IgE, immunoglobulin E; FEV1, forced expiratory volume in 1 second; FVC, forced 
expiratory vital capacity; FEF25-75, forced expiratory flow between 25% and 
75%. 
Table 2. The methacholine challenge test and measurement of fractional ex-
haled nitric oxide in the asthma, allergic rhinitis, and control groups
Asthma
(n=112)
Allergic rhinitis
(n=196)
Control
(n=32)
BHR (no [%]) 107 (96)*† 24 (12)* 0 (0)
FeNO (ppb) 50.4 (26.0/80.9)*† 30.0 (16.3/49.8)* 18.9 (12.3/38.2)
Data expressed as median (interquartile range).
*P<0.05 vs. control; †P<0.05 vs. Allergic Rhinitis.
BHR, bronchial hyper-responsiveness; FeNO, Fractional Exhaled Nitric Oxide.
are shown in Table 2. BHR was observed in 96% of the subjects 
in the asthma group and 12% of those in the AR group; it was 
significantly higher in the asthma and AR groups than in the 
control group (P<0.0001 and P=0.031, respectively). FeNO lev-
els was higher in the asthma group than in the AR group 
(P<0.0001) and in the AR group than in the control group 
(P=0.005). In the total subjects, FeNO levels significantly corre-
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FEV1 and % change in FEF25-75 were higher in the asthma group 
than in the AR and control groups (P<0.0001). The difference 
in resistance, as measured in % change, between 5 and 20 Hz (Δ 
R5-R20) and the differences in R5 (Δ R5), R10 (Δ R10), X5 (Δ 
X5), and AX (Δ AX) were also higher in the asthma group than 
in the AR and control groups (the asthma vs. AR groups: Δ R5-
R20, P=0.001; Δ R5, P<0.0001; Δ R10, P=0.006; Δ X5, P<0.0001; 
Δ AX, P<0.0001)(the asthma vs. control groups: Δ R5-R20, P=  
0.009; Δ R5, P=0.001; Δ R10, P=0.033; Δ X5, P<0.0001; Δ AX, P< 
0.0001). The variables Δ X5 and Δ AX were the indices of BDR, 
which were more elevated in the AR group than in the control 
group (P=0.012; P=0.022).
Comparison of AR with and without BHR
Serum total IgE levels and blood eosinophil counts were sig-
nificantly higher in the AR group with BHR than in the AR 
group without, as shown in E-Table 2 (P=0.026 and P=0.009, 
respectively). Skin tests were performed on 135 children of the 
AR group. There was no significant difference in positive skin 
reactions between the 2 groups. The AR group with BHR tend-
E-Table 2. Comparison of allergic rhinitis with and without BHR
Allergic rhinitis with 
BHR (n = 24)
Allergic rhinitis without 
BHR (n = 172)
Total IgE (IU/mL) 392 (196/1242)* 237 (129/472)
Blood eosinophil (µL-1) 460 (310/800)* 340 (170/550)
Positive skin test 
(n=135), (no [%])
18/18 (100) 111/117 (95)
FeNO (ppb) 42.3 (30.5/74.7) 27.3 (15.8/49.4)
Impulse Oscillometry
% change in X5 -13.6 (-41.9/2.3) -20.0 (-35.0/-2.0)
% change in AX -27.5 (-47.2/-4.1) -30.1 (-43.6/-10.4)
Data expressed as median (interquartile range).
*P<0.05 vs. Allergic Rhinitis without BHR.
BHR, bronchial hyper-responsiveness; IgE, immunoglobulin E; FeNO, fractional 
exhaled nitric oxide; X5, reactance at 5 Hz; AX, reactance area.
Table 3. Bronchodilator response on spirometry and impulse oscillometry in the asthma, allergic rhinitis, and control groups
Asthma (n=112) Allergic rhinitis (n=196) Control (n=32)
Spirometry
% change in FEV1 9.2 (3.9/15.1)*† 3.0 (0.3/6.2) 2.2 (0.1/4.2)
% change in FEF25-75 30.9 (15.5/50.4)*† 12.8 (5.3/22.6) 11.6 (4.9/19.2)
Impulse oscillometry
% change in R5-R20 -16.2 (-26.9/-5.7)*† -12.0 (-19.0/-3.1) -10.9 (-16.2/-3.7)
% change in R5 -19.5 (-31.2/-10.0)*† -14.7 (-21.7/-6.4) -12.7 (-18.2/-2.1)
% change in R10 -13.8 (-23.5/-13.8)*† -9.0 (-17.5/-1.9) -8.9 (-14.5/-4.2)
% change in X5 -32.4 (-49.3/-18.4)*† -19.8 (-35.8/-0.5)* -7.9 (-19.3/5.3)
% change in AX -43.9 (-59.8/-27.4)*† -29.9 (-43.9/-9.7)* -16.6 (-35.3/5.5)
Data expressed as median (interquartile range).
*P<0.05 vs. control; †P<0.05 vs. allergic rhinitis.
FEV1, forced expiratory volume in 1 second; FEF25-75, forced expiratory flow between 25% and 75%; R5-R20, difference in resistance between 5 Hz and 20 Hz; R5, 
resistance at 5 Hz; R10, resistance at 10 Hz; X5, reactance at 5 Hz; AX, reactance area.
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Figure. (A) Fractional exhaled nitric oxide (FeNO) in the control group, the aller-
gic rhinitis (AR) group with bronchial hyper-responsiveness (BHR), the AR group 
without, and the asthma group. FeNO levels were higher in the asthma and AR 
groups than in the control group. The AR group with BHR tended to have higher 
FeNO than the AR group without (P=0.08). (B) BDR in reactance at 5 Hz (Δ X5) 
and reactance area (Δ AX) increased more in the asthma and AR groups than in 
the control group. Moreover, Δ X5 and Δ AX were not significantly different be-
tween the AR group with BHR and the AR group without.
E-Table 1. Correlation between FeNO and PC20 levels in total and allergic rhini-
tis subjects
Correlation coefficient P value
Total subjects (n=340) -0.337 <0.0001
Allergic rhinitis subjects (n=196) -0.175 0.045
FeNO, fractional exhaled nitric oxide.
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ed to have higher FeNO levels than the AR group without (P=  
0.08) (E-Table 2, Figure A). FeNO levels significantly correlated 
with PC20 levels (r=-0.175, P=0.045) in the AR group (E-Table 
1). Since Δ X5 and Δ AX were significantly higher in the AR 
group than in the control group, comparisons of these values 
were made between the AR group with BHR and the AR group 
without; however, no difference was statistically not significant 
(E-Table 2, Figure B). 
 
DISCUSSION
Our study compared pulmonary function parameters and 
FeNO levels between the AR, asthma, and control groups. It 
also compared these parameters between the AR group with 
BHR and the AR group without. We demonstrated for the first 
time that BDR parameters, as determined by IOS (Δ X5 and Δ 
AX), may detect mild reversible airway obstruction in children 
with AR that cannot be detected by spirometry. We also found 
elevated FeNO levels in the AR group and a tendency for FeNO 
to rise in the AR group with BHR than in the AR group without. 
When Δ X5 and Δ AX were compared, there was no significant 
difference between the AR group with BHR and the AR group 
without.
It has long been debated whether BHR correlates simply with 
BDR because pathologic mechanisms in asthma, such as air-
way remodeling, are very complicated.22-24 Regardless, BHR and 
BDR have been accepted to be clinically important, indepen-
dent indices that represent the pathology of asthma. In this 
study, BDR assessed using IOS, Δ X5, and Δ AX, did not corre-
late with BHR. It appears that the use of IOS to assess BDR in 
evaluating early bronchial involvement in AR may offer more 
information than the use of BHR (as measured by the MCT) 
alone.
IOS systems are increasingly being used in the clinical setting 
to test for airway obstruction and BDR.13 Reactance at 5 Hz (X5) 
reflects the elastic recoil of the peripheral airway, while the AX 
is a composite index of reactance.21 As confirmed by our study, 
these parameters are more sensitive in detecting changes in 
pulmonary function than spirometric results.25 Although FEF25-
75 has also emerged as a good predictor of mild airway hyperre-
sponsiveness or variable airway obstruction in AR,26 it did not 
distinguish AR from control subjects in our study, even when 
AR subjects were subdivided into those with and without BHR 
(data not shown).
FeNO was significantly higher in the asthma and AR groups 
than in the control group; within the AR group, the AR group 
with BHR had higher FeNO levels than the AR group without, 
but this difference was not statistically significant. FeNO levels 
also showed a significant correlation with PC20 levels in both 
total and AR subjects, respectively. It appears that FeNO may 
correlate with BHR in AR. This finding is supported by many 
studies that have attempted to replace BHR in the MCT with 
FeNO.27,28 Chronic airway inflammation secondary to allergic 
sensitization has been associated with not only increased 
FeNO, but also BHR.29,30 This finding is also supported by our 
result indicating that elevated total serum IgE levels and blood 
eosinophil counts were elevated in asthma and AR subjects, es-
pecially in AR subjects with BHR.
One potential strength of this study was careful selection of 
subjects to eliminate confounders. We only included atopic 
children in all groups to eliminate confounding factors from 
baseline airway inflammation that might increase FeNO level 
and BDR.14,31 Additionally, we excluded children with asthma 
but without AR. We considered the likelihood that asthma de-
velops under different mechanisms when AR is not present due 
to the complex relationship between asthma and AR.32
Our study has some limitations. Although we only selected 
atopic children in all groups, the control group showed lower 
levels of total serum IgE and fewer positive skin test reactions 
than the other groups. We did not consider different degrees of 
atopic sensitization among the 3 groups. Second, since we did 
not obtain follow-up data, we could not confirm the develop-
ment of asthma. Third, since the MCT, which is used to mea-
sure BHR, was performed through forced expiration on spirom-
etry, while BDR was assessed using IOS. The use of different di-
agnostic tools for these 2 parameters may have introduced a 
measurement bias. Therefore, further studies with a prospec-
tive design that evaluate BHR and BDR using IOS are needed to 
understand lower airway pathology in AR.
In conclusion, children with AR have mild reversible airway 
obstruction that can be detected using IOS, in addition to ele-
vated airway inflammation as indicated by higher FeNO. The 
tendency toward higher FeNO levels in the AR group with BHR 
than in the AR group without BHR represents that FeNO may 
be a useful tool for assessing BHR in AR. Furthermore, Δ X5 and 
Δ AX can be useful parameters for assessing lower airway in-
volvement in AR independent of BHR in the MCT. These con-
clusions support the concept of a united airway disease of asth-
ma and AR.4 
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